Clinical Trial: Prostatic Hyperplasia Treatment and Cancer Prevention

Study Status: Not yet recruiting
Recruit Status: Not yet recruiting
Study Type: Interventional

Official Title: Treatment of Prostatic Hyperplasia With Topical Papaverine

Brief Summary: Treatment of patients with prostatic hyperplasia with topical papaverine.

Detailed Summary: Patients with obstructive voiding and high PSA to be studied for the regression of symptoms and declining PSA.
Sponsor: Manchanda Medical Clinic

Current Primary Outcome: Laboratory tests to measure regression of symptoms [ Time Frame: every 4 weeks up to 16 weeks ]

patients follow-up on regular intervals


Original Primary Outcome: Laboratory tests to measure regression of symptoms [ Time Frame: every 4 weeks up to 16 weeks ]

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Manchanda Medical Clinic

Dates:
Date Received: December 12, 2016
Date Started: April 20, 2017
Date Completion: June 30, 2017
Last Updated: March 21, 2017
Last Verified: March 2017